middle.news

Cambium Bio Expands Reach with Benta SAS for Elate Ocular in Europe and Middle East

12:11pm on Friday 5th of September, 2025 AEST • Healthcare
Read Story

Cambium Bio Expands Reach with Benta SAS for Elate Ocular in Europe and Middle East

12:11pm on Friday 5th of September, 2025 AEST
Key Points
  • Memorandum of Understanding signed with Benta SAS for exclusive rights in Europe and Middle East
  • Elate Ocular (CAM-101) targets dry eye disease using platelet-lysate regenerative medicine
  • Second platelet-lysate licensing deal in three days, following US$2M+ Keke MedTech agreement
  • Potential business models include direct licensing, joint venture, or new corporate entity
 Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about CMB
OPEN ARTICLE